Health Care & Life Sciences » Biotechnology | Applied Genetic Technologies Corp.

Applied Genetic Technologies Corp. | Ownership

Companies that own Applied Genetic Technologies Corp.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Dimensional Fund Advisors LP
731,898
4.05%
99,358
0%
06/30/2018
Acadian Asset Management LLC
686,732
3.8%
-4,154
0.01%
06/30/2018
Renaissance Technologies LLC
634,500
3.52%
140,700
0%
06/30/2018
The Vanguard Group, Inc.
486,062
2.69%
44,685
0%
06/30/2018
T. Rowe Price Associates, Inc.
454,429
2.52%
264,448
0%
06/30/2018
DAFNA Capital Management LLC
421,000
2.33%
0
0.73%
06/30/2018
Numeric Investors LLC
388,768
2.15%
-86,824
0.01%
06/30/2018
AJO LP
364,224
2.02%
-39,866
0.01%
06/30/2018
683 Capital Management LLC
300,000
1.66%
0
0.15%
06/30/2018
BlackRock Fund Advisors
263,403
1.46%
-33,083
0%
06/30/2018

About Applied Genetic Technologies

View Profile
Address
14193 NW
Alachua Florida 32615
United States
Employees -
Website http://www.agtc.com
Updated 07/08/2019
Applied Genetic Technologies Corp. is a clinical-stage biotechnology company, which engages in the development of gene therapy products designed to transform the lives of patients with severe diseases in ophthalmology. Its product candidates are designed to treat X-linked retinoschisis, Achromatopsia, and X-linked retinitis pigmentosa. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.